Delivery Order SPE2DB25D3005-SPE2DB25FQCCB
Award Date
1/30/25
Potential Completion Date
1/31/25
Potential Value
$6.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,455.27, is a Firm Fixed Price Delivery Order for the supply of Telmisartan-HCTZ 80-25 mg Tablets in units of 30. The contract has an Ultimate Completion Date of December 27, 2024. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen also holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,966.87, is for the delivery of Telmisartan-HCTZ 40-12.5 mg tablets in 30-count units. The contract has an ultimate completion date of January 10, 2025 and is a firm fixed-price delivery order. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, worth $4,548.98, is for the delivery of Telmisartan-HCTZ 80-12.5 mg tablets in 30-count units. The contract has a firm fixed price and an ultimate completion date of February 5, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,898.67 firm fixed-price delivery order is for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in 30-count units. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,017.19 firm-fixed-price delivery order is for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit doses of 30s. The contract has an ultimate completion date of October 29, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Telmisartan-HCTZ 80-25 mg tablets. The $4,144.42 firm fixed-price delivery order has a completion date of November 29, 2024 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Telmisartan-HCTZ 80-25 mg tablets in 30-count packages. The $10,297.32 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, on September 11, 2024 with a completion date of September 12, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999...
This federal contract award, valued at $43,217.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Telmisartan-HCTZ 40-12.5 mg tablets, a prescription medication, with an ultimate completion date of August 16, 2024. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,412.35, is for the delivery of Telmisartan-HCTZ 80-12.5 mg tablets in 30-count units. The contract type is Firm Fixed Price and it is set to expire on January 29, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $10,775.61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging, with a completion date of December 10, 2024. This award is not associated with a set-aside program and represents a firm fixed-price delivery order. Amerisourcebergen Drug Corp, a for-profit...